Overview
BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management
Status:
Completed
Completed
Trial end date:
2009-08-01
2009-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Arena Pharmaceuticals
Eisai Inc.
Criteria
Inclusion Criteria:- Overweight and/or obese men and women with a body mass index (BMI) 30 to 45 kg/m2 with
or without a comorbid condition (e.g., hypertension, dyslipidemia, CV disease, glucose
intolerance, sleep apnea), or 27 to 29.9 kg/m2 with at least one comorbid condition.
- Ability to complete a 1 year study
Exclusion Criteria:
- Pregnancy
- Diabetes mellitus (type I, II or other)
- History of symptomatic heart valve disease
- Serious or unstable current or past medical conditions